
    
      The secondary objectives of this protocol evaluated the effect of this transplant procedure
      on the subsequent clinical course of patients with severe SCD. Specifically, to determine
      whether pre-transplant organ dysfunction (brain, heart, lung, kidney, liver, spleen, etc)
      resultant from sickle hemoglobinopathy can be reversed following this particular transplant
      procedure.
    
  